Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Oct;84(4):1070–1075. doi: 10.1172/JCI114269

Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.

A W van den Wall Bake 1, W E Beyer 1, J H Evers-Schouten 1, J Hermans 1, M R Daha 1, N Masurel 1, L A van Es 1
PMCID: PMC329762  PMID: 2794045

Abstract

Primary IgA nephropathy (IgAN) is characterized by mesangial deposits of IgA1, increased serum IgA1 levels, and circulating immune complexes containing predominantly IgA1. It has previously been found that patients with IgAN have a higher than normal IgA response to vaccination, but the IgA subclasses have not been studied. To investigate whether the IgA hyperresponsiveness is limited to the subclass IgA1, which is involved in the pathogenesis of IgAN, we compared the immune responses of 18 patients with 22 healthy controls after intramuscular vaccination with inactivated influenza virus. Antibody titers were significantly higher (P less than 0.0001) for the IgA1 subclass in patients versus controls, but not for the other isotypes. A substantial portion of the IgA and IgA1 antiinfluenza immune response comprised polymers in both patients and controls. There was no preferential response of polymers in patients. Patients produced significantly more monomeric IgA1 antibodies than controls. These results show that patients with IgAN have a hyperresponsiveness limited to the subclass IgA1 and mainly expressed by an excess of monomers.

Full text

PDF
1072

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beagley K. W., Eldridge J. H., Kiyono H., Everson M. P., Koopman W. J., Honjo T., McGhee J. R. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol. 1988 Sep 15;141(6):2035–2042. [PubMed] [Google Scholar]
  2. Bene M. C., Faure G., Duheille J. IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol. 1982 Mar;47(3):527–534. [PMC free article] [PubMed] [Google Scholar]
  3. Brown T. A., Mestecky J. Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun. 1985 Aug;49(2):459–462. doi: 10.1128/iai.49.2.459-462.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown T. A., Murphy B. R., Radl J., Haaijman J. J., Mestecky J. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol. 1985 Aug;22(2):259–264. doi: 10.1128/jcm.22.2.259-264.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clarkson A. R., Seymour A. E., Thompson A. J., Haynes W. D., Chan Y. L., Jackson B. IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol. 1977 Nov;8(5):459–471. [PubMed] [Google Scholar]
  6. Clarkson A. R., Seymour A. E., Woodroffe A. J., McKenzie P. E., Chan Y. L., Wootton A. M. Controlled trial of phenytoin therapy in IgA nephropathy. Clin Nephrol. 1980 May;13(5):215–218. [PubMed] [Google Scholar]
  7. Conley M. E., Cooper M. D., Michael A. F. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest. 1980 Dec;66(6):1432–1436. doi: 10.1172/JCI109998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Czerkinsky C., Koopman W. J., Jackson S., Collins J. E., Crago S. S., Schrohenloher R. E., Julian B. A., Galla J. H., Mestecky J. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest. 1986 Jun;77(6):1931–1938. doi: 10.1172/JCI112522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987 Sep;64(245):709–727. [PubMed] [Google Scholar]
  10. Delacroix D. L., Elkom K. B., Geubel A. P., Hodgson H. F., Dive C., Vaerman J. P. Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest. 1983 Feb;71(2):358–367. doi: 10.1172/JCI110777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Doi T., Kanatsu K., Sekita K., Yoshida H., Nagai H., Hamashima Y. Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy. J Immunol Methods. 1984 Apr 13;69(1):95–104. doi: 10.1016/0022-1759(84)90281-3. [DOI] [PubMed] [Google Scholar]
  12. Endoh M., Suga T., Miura M., Tomino Y., Nomoto Y., Sakai H. In vivo alteration of antibody production in patients with IgA nephropathy. Clin Exp Immunol. 1984 Sep;57(3):564–570. [PMC free article] [PubMed] [Google Scholar]
  13. Feehally J., Beattie T. J., Brenchley P. E., Coupes B. M., Mallick N. P., Postlethwaite R. J. Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int. 1986 Dec;30(6):924–931. doi: 10.1038/ki.1986.274. [DOI] [PubMed] [Google Scholar]
  14. Hall R. P., Stachura I., Cason J., Whiteside T. L., Lawley T. J. IgA-containing circulating immune complexes in patients with igA nephropathy. Am J Med. 1983 Jan;74(1):56–63. doi: 10.1016/0002-9343(83)91118-x. [DOI] [PubMed] [Google Scholar]
  15. Harriman G. R., Strober W. Interleukin 5, a mucosal lymphokine? J Immunol. 1987 Dec 1;139(11):3553–3555. [PubMed] [Google Scholar]
  16. Hiemstra P. S., Baldwin W. M., van der Voort E. A., Paul L. C., van Es L. A., Daha M. R. Polymeric IgA antibody response to rabbit antithymocyte globulin in renal transplant recipients. Transplantation. 1988 Apr;45(4):701–705. doi: 10.1097/00007890-198804000-00007. [DOI] [PubMed] [Google Scholar]
  17. Jones C., Mermelstein N., Kincaid-Smith P., Powell H., Roberton D. Quantitation of human serum polymeric IgA, IgA1 and IgA2 immunoglobulin by enzyme immunoassay. Clin Exp Immunol. 1988 May;72(2):344–349. [PMC free article] [PubMed] [Google Scholar]
  18. Katz A., Newkirk M. M., Klein M. H. Circulating and mesangial IgA in IgA nephropathy. Contrib Nephrol. 1984;40:74–79. doi: 10.1159/000409731. [DOI] [PubMed] [Google Scholar]
  19. Kett K., Brandtzaeg P., Radl J., Haaijman J. J. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol. 1986 May 15;136(10):3631–3635. [PubMed] [Google Scholar]
  20. Leinikki P. O., Mustonen J., Pasternack A. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Clin Exp Immunol. 1987 Apr;68(1):33–38. [PMC free article] [PubMed] [Google Scholar]
  21. Lesavre P., Digeon M., Bach J. F. Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol. 1982 Apr;48(1):61–69. [PMC free article] [PubMed] [Google Scholar]
  22. Lomax-Smith J. D., Zabrowarny L. A., Howarth G. S., Seymour A. E., Woodroffe A. J. The immunochemical characterization of mesangial IgA deposits. Am J Pathol. 1983 Dec;113(3):359–364. [PMC free article] [PubMed] [Google Scholar]
  23. Lue C., Tarkowski A., Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol. 1988 Jun 1;140(11):3793–3800. [PubMed] [Google Scholar]
  24. Mascart-Lemone F. O., Duchateau J. R., Oosterom J., Butzler J. P., Delacroix D. L. Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. J Clin Microbiol. 1987 Jul;25(7):1253–1257. doi: 10.1128/jcm.25.7.1253-1257.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mascart-Lemone F., Duchateau J., Conley M. E., Delacroix D. L. A polymeric IgA response in serum can be produced by parenteral immunization. Immunology. 1987 Aug;61(4):409–413. [PMC free article] [PubMed] [Google Scholar]
  26. Monteiro R. C., Halbwachs-Mecarelli L., Roque-Barreira M. C., Noel L. H., Berger J., Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int. 1985 Oct;28(4):666–671. doi: 10.1038/ki.1985.181. [DOI] [PubMed] [Google Scholar]
  27. Murray P. D., McKenzie D. T., Swain S. L., Kagnoff M. F. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol. 1987 Oct 15;139(8):2669–2674. [PubMed] [Google Scholar]
  28. Nagy J., Brandtzaeg P. Tonsillar distribution of IgA and IgG immunocytes and production of IgA subclasses and J chain in tonsillitis vary with the presence or absence of IgA nephropathy. Scand J Immunol. 1988 Apr;27(4):393–399. doi: 10.1111/j.1365-3083.1988.tb02362.x. [DOI] [PubMed] [Google Scholar]
  29. Negro Ponzi A., Merlino C., Angeretti A., Penna R. Virus-specific polymeric immunoglobulin A antibodies in serum from patients with rubella, measles, varicella, and herpes zoster virus infections. J Clin Microbiol. 1985 Oct;22(4):505–509. doi: 10.1128/jcm.22.4.505-509.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Newkirk M. M., Klein M. H., Katz A., Fisher M. M., Underdown B. J. Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver disease. J Immunol. 1983 Mar;130(3):1176–1181. [PubMed] [Google Scholar]
  31. Pasternack A., Mustonen J., Leinikki P. Humoral immune response in patients with IgA and IgM glomerulonephritis. Clin Exp Immunol. 1986 Jan;63(1):228–233. [PMC free article] [PubMed] [Google Scholar]
  32. Sato M., Kojima H., Takayama K., Koshikawa S. Glomerular deposition of food antigens in IgA nephropathy. Clin Exp Immunol. 1988 Aug;73(2):295–299. [PMC free article] [PubMed] [Google Scholar]
  33. Tesch H., Müller W., Rajewsky K. Lymphokines regulate immunoglobulin isotype expression in an antigen-specific immune response. J Immunol. 1986 Apr 15;136(8):2892–2895. [PubMed] [Google Scholar]
  34. Tomino Y., Endoh M., Nomoto Y., Sakai H. Immunoglobulin A1 and IgA nephropathy. N Engl J Med. 1981 Nov 5;305(19):1159–1160. doi: 10.1056/NEJM198111053051922. [DOI] [PubMed] [Google Scholar]
  35. Tomino Y., Miura M., Suga T., Endoh M., Nomoto Y., Sakai H. Detection of IgA1-dominant immune complexes in peripheral blood polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Nephron. 1984;37(2):137–139. doi: 10.1159/000183230. [DOI] [PubMed] [Google Scholar]
  36. Tomino Y., Sakai H., Miura M., Endoh M., Nomoto Y. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol. 1982 Aug;49(2):419–425. [PMC free article] [PubMed] [Google Scholar]
  37. Trascasa M. L., Egido J., Sancho J., Hernando L. IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol. 1980 Nov;42(2):247–254. [PMC free article] [PubMed] [Google Scholar]
  38. Valentijn R. M., Radl J., Haaijman J. J., Vermeer B. J., Weening J. J., Kauffmann R. H., Daha M. R., van Es L. A. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int. 1984 Nov;26(5):760–766. doi: 10.1038/ki.1984.213. [DOI] [PubMed] [Google Scholar]
  39. Woodroffe A. J., Gormly A. A., McKenzie P. E., Wootton A. M., Thompson A. J., Seymour A. E., Clarkson A. R. Immunologic studies in IgA nephropathy. Kidney Int. 1980 Sep;18(3):366–374. doi: 10.1038/ki.1980.147. [DOI] [PubMed] [Google Scholar]
  40. van den Wall Bake A. W., Daha M. R., Haaijman J. J., Radl J., van der Ark A., van Es L. A. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int. 1989 Jun;35(6):1400–1404. doi: 10.1038/ki.1989.139. [DOI] [PubMed] [Google Scholar]
  41. van den Wall Bake A. W., Daha M. R., Radl J., Haaijman J. J., Van der Ark A., Valentijn R. M., Van Es L. A. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol. 1988 May;72(2):321–325. [PMC free article] [PubMed] [Google Scholar]
  42. van den Wall Bake A. W., Daha M. R., van der Ark A., Hiemstra P. S., Radl J., van Es L. A. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol. 1988 Oct;74(1):115–120. [PMC free article] [PubMed] [Google Scholar]
  43. van der Peet J., Arisz L., Brentjens J. R., Marrink J., Hoedemaeker P. J. The clinical course of IgA nephropathy in adults. Clin Nephrol. 1977 Aug;8(2):335–340. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES